MedTrace Logo

HU007 Eye Drops in Patients With Dry Eye Syndrome

NCT04384991 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2020-05-12

No results posted yet for this study

Summary

This study is a multicenter, randomized, double blind, Restasis-controlled non-inferiority, Phase III Study to evaluate the efficacy and safety of HU007 eye drops in patients With dry eye syndrome

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

HU007

Cyclosporine 0.02% with Trehalose 3%

DRUG

Restasis eye drop

Cyclosporine 0.05%

Sponsors & Collaborators

  • Huons Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-03
Primary Completion
2019-12-05
Completion
2019-12-05

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384991 on ClinicalTrials.gov